ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $67,000 | +19.6% | 11,112 | -29.0% | 0.00% | – |
| Q3 2019 | $56,000 | +16.7% | 15,658 | -11.7% | 0.00% | – |
| Q2 2019 | $48,000 | -7.7% | 17,735 | 0.0% | 0.00% | – |
| Q1 2019 | $52,000 | +173.7% | 17,735 | +46.4% | 0.00% | – |
| Q4 2018 | $19,000 | -58.7% | 12,112 | -2.6% | 0.00% | – |
| Q3 2018 | $46,000 | +35.3% | 12,432 | +3.4% | 0.00% | – |
| Q2 2018 | $34,000 | -29.2% | 12,022 | -6.4% | 0.00% | – |
| Q1 2018 | $48,000 | +50.0% | 12,842 | +15.3% | 0.00% | – |
| Q4 2017 | $32,000 | -40.7% | 11,142 | -7.2% | 0.00% | – |
| Q3 2017 | $54,000 | +1.9% | 12,002 | +3.2% | 0.00% | – |
| Q2 2017 | $53,000 | +8.2% | 11,632 | 0.0% | 0.00% | – |
| Q1 2017 | $49,000 | +2.1% | 11,632 | 0.0% | 0.00% | – |
| Q4 2016 | $48,000 | -48.9% | 11,632 | 0.0% | 0.00% | – |
| Q3 2016 | $94,000 | +10.6% | 11,632 | +7.3% | 0.00% | – |
| Q2 2016 | $85,000 | -30.9% | 10,842 | -33.3% | 0.00% | – |
| Q2 2014 | $123,000 | – | 16,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,733,815 | $81,081,000 | 11.64% |
| RTW INVESTMENTS, LP | 2,589,818 | $17,896,000 | 5.56% |
| DAFNA Capital Management LLC | 480,300 | $3,319,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 510,125 | $3,525,000 | 1.83% |
| Sio Capital Management, LLC | 364,368 | $2,518,000 | 1.73% |
| TURNER INVESTMENTS LLC | 1,086,000 | $7,504,000 | 1.52% |
| Ghost Tree Capital, LLC | 300,000 | $2,073,000 | 0.93% |
| Rock Springs Capital Management LP | 1,125,000 | $7,774,000 | 0.63% |
| SENZAR ASSET MANAGEMENT, LLC | 619,000 | $4,277,290,000 | 0.62% |
| Point72 Asset Management, L.P. | 9,772,018 | $67,525,000 | 0.53% |